Abstract
The inoperable esophageal cancers subjected to telecobalt therapy at the National Cancer Institute, Milan, between June 1958 and June 1966 are reviewed. The series consists of 78 patients who received a «curative» dose, that is over 4000 rad to the tumor. The anatomical, clinical and Xray data are shown in the tables. The technicalities and dose-levels are discussed. 23 patients survived for over a year; the average survival for the whole series was a little under 10 months. The useful dose is thought to be about 6000 rad in 2 months, where possible.
Get full access to this article
View all access options for this article.
